This report summarizes the human papillomavirus (HPV) vaccination program implemented in Vietnam by PATH, the Vietnam National Institute of Hygiene and Epidemiology, and the Vietnam National Center for Health Education and Communication through the …

This report addresses issues related to financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms, which will constitute some of the most significant challenges to achieving widespread HPV …

This issue brief provides important new evidence on the safety of HPV vaccines, including information on vaccine safety reporting systems, the safety profile of HPV vaccines, and the use of HPV vaccines in special populations. This brief is designed …

Cervical cancer, which is caused by human papillomavirus (HPV), is estimated to have been responsible for almost 260,000 deaths in 2005. Eighty percent of these deaths occurred in developing countries. Fortunately, in 2006 a vaccine that protects …

This report identifies country-level strategies to reach the one in five children that are missing out on basic vaccinations. It also identifies factors at the global level that will help to create a more conducive environment for countries to …

An overview of immunization support to developing countries provided through the GAVI Alliance.

Financing is a critical component of a sustainable immunization program. This toolkit is comprised of a series of short briefs on different options for financing national immunization programs and vaccines. It is intended to serve as a resource for …

This report summarizes workshops held in July 2010 by Project Optimize (a collaboration between PATH and the World Health Organization) in Washington, DC, and Seattle to engage stakeholders from a wide variety of organizations related to …

The US Centers for Disease Control and Prevention and the US National Institutes of Health recognized the need for an independent group to carefully examine the hypothesized measles-mumps-rubella vaccine and autism link and address other …

This report contains results of a review completed by the Immunization Safety Review Committee of epidemiologic evidence on Sudden Unexpected Death in Infancy (SUDI) and neonatal death. The committee found that the evidence did not support a causal …

This eighth and final report of the Immunization Safety Review Committee examines the hypothesis that vaccines, specifically the measles-mumps-rubella vaccine and thimerosal-containing vaccines, are causally associated with autism.

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

The main purpose of this document--part of the Immunological Basis for Immunization series--is to give vaccination professionals (e.g., EPI managers) a brief and easy-to-understand overview of the scientific basis of vaccination regarding …

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

This report documents an African regional conference on cervical cancer prevention held in September 2010 in Kampala, Uganda. Representatives from nine African countries met to share updates on cervical cancer vaccination and screening programs, and …

This report summarizes the results of a six-month inquiry by the UK All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) on the global disease burden of pneumococcal disease and pneumonia, …

This report presents results from an economic model that calculates the costs involved in delivering IPV vaccine in Indian immunization clinics according to three strategies: (1) intradermal delivery of reduced volumes of vaccine per …

This short paper describes in some detail how Ugandan communities were involved in improving immunization services. The paper includes an annex with common questions posed by community members, and suggested answers, in both English and French.

This paper analyzes the current supply of influenza vaccines, the predicted demand for influenza vaccines in case of a pandemic, and new vaccine technologies that could provide for the world’s demand in a pandemic situation.

This document outlines current and future plans, objectives, and milestones for the department dedicated to vaccines and immunization at the World Health Organization (WHO). This long-term strategic plan takes account of the evolving vaccine …

The purpose of this report is: (1) to summarize the clinical evidence supporting the intradermal route for vaccine administration and the devices being developed for this purpose; (2) to determine whether intradermal delivery broadly holds promise …

As a supplement to GAVI’s detailed guidelines, the document aims to support decision-making by GAVI-eligible countries in the WHO European region and provides information on the burden of rotavirus disease; efficacy, safety, and …

Published in Immunization Forum, a publication of the GAVI Alliance, this article discusses JE, including surveillance and reporting of the disease as well as prevention and treatment.

This strategic plan, prepared by PATH from the contributions of 17 partner organizations, provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis (JE) control, including improved …

This document is an excerpt from the World Health Organization-recommended standards for surveillance of selected vaccine-preventable diseases, including Japanese encephalitis.